Administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta and the amount of blood loss vaginally.
Retained placenta (RP)is one of the complications of third stage of labour; it should be managed promptly as it may cause severe bleeding, infection, maternal morbidity and mortality .The current standard management of RP word wide, by manual removal aims to prevent these problems, but it is unsatisfactory method because it requires general anaesthesia in hospital, It is an invasive procedure with its own serious complications of bleeding, infection and genital tract injury. Umbilical vein injection of misoprostol is a simple, safe method and could be performed at the place of delivery .
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
46
It is a synthetic prostaglandin (PgE1 analogue)used as a uterotonic substance.
It is a placebo group
Maternity Teaching Hospital
Erbil, Kurdistan Region, Iraq
delivery of placenta by medical intervention
The administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta under general anaesthesia.
Time frame: 30 minutes after the injection of misoprostol or normal saline in the umbilical vein
vaginal bleeding after misoprostol use
using intraumbilical misoprostol in women with retained placenta reduces the amount of blood loss vaginally.
Time frame: 30 minutes after umbilical vein injection of misoprostol
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.